Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the correct purchasers needs, the drug will fail to reach its intended market value. This book, written by Professor Mondher Toumi, is based on an accredited course in this area out of The European Market Access University Diploma (EMAUD) and affiliated with Aix Marseille University. The book contains case studies, scenarios, and market access considerations for USA, Western Europe, Japan and China. The book is published by CRC Press, and available for US$129.95. To order, click here.
You are here: / / New Book Release: Introduction to Market Access for Pharmaceuticals